Overview

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AZ Jan Palfijn Gent
Collaborator:
Onze Lieve Vrouw Hospital
Treatments:
Chorionic Gonadotropin
Deslorelin
Triptorelin Pamoate
Criteria
Inclusion Criteria:

- Intra-cytoplasmic sperm injection (ICSI) patients below 38 years

- 1,2 or 3 rd IVF-cycle

Exclusion Criteria:

- polycystic ovary syndrome (PCOS) patients

- patients with endocrinological diseases or problems